RC BIOTECHNOLOGIES INC has a total of 12 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are CINDA PHARMA AB, LUMOSA THERAPEUTICS CO LTD and EHRENPREIS ELI D.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Russian Federation | 1 | |
#10 | Taiwan | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ye Hui | 10 |
#2 | Fang Jianmin | 10 |
#3 | Huang Chang Jiang | 8 |
#4 | Zhang Lezhi | 7 |
#5 | Zhang Lezi | 3 |
#6 | Huang Changjiang | 2 |
#7 | Fan Tszyanmin | 1 |
#8 | Chang Jiang Huang | 1 |
#9 | Lezhi Zhang | 1 |
#10 | Khuan Chan Tszyan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017031034A2 | Covalent linkers in antibody-drug conjugates and methods of making and using the same |